Ultima Pharmaceuticals supplies this peptide as a single 10 ml vial holding 1 mg of IGF-1 LR3, prepared for injection once reconstituted. The substance arrives lyophilized, sealed in glass, and labeled with batch details and expiry. Ultima Pharmaceuticals, based in the USA, has manufactured peptides since 2022.

IGF-1 LR3 at 1 mg in a 10 ml Vial

Each vial carries 1 mg of the peptide across 10 ml when mixed, giving 0.1 mg per ml after reconstitution. The pack holds one vial, and the form is injectable. Other labs list IGF-1 LR3 in smaller volumes or at different concentrations—Sixpex offers a variant, and Beligas Pharma lists IGF DES at the same 1 mg dosage but in a different peptide structure. Where you need a 10 ml format at this concentration, this vial matches that specification directly.

The lyophilized powder requires sterile water or bacteriostatic water to prepare for injection. Vial presentation ensures the peptide remains stable until reconstitution, and the glass seal protects contents during storage. The label prints dosage, volume, and substance name, letting you confirm what the pack contains before opening. Ultima Pharmaceuticals also lists TB 500 5Mg and other research peptides in the catalog peptides section, each supplied in vial form with stated milligram content.